Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GeneOhm Sciences Inc.

Division of Becton Dickinson & Co.
www.geneohm.com

Latest From GeneOhm Sciences Inc.

New Technologies Help Hospitals Tackle Patient Safety Push

CMS continues to tighten its rules on so-called "never events" - conditions acquired during hospitalization - in an ongoing effort to slash Medicare costs and improve care for hospitalized patients. And the HAC rules currently in place have already provided significant impetus for hospitals to take steps to improve the identification and prevention of nosocomial infections. Nowa growing group of companies with innovative new technologies aim to capitalize on this trend by helping hospitals take their efforts even further.
Medical Device

Does Roche Have It Right?

Roche's hostile tender offer for Ventana Medical Systems, and to a lesser extent its recent acquisitions of life science tools companies this year, highlight the firm's belief in diagnostics and its bet that personalized medicine--an area where innovative platforms and molecular test content will play significant if separate roles--will be key to its long-term growth. It could be an expensive and risky strategy that will take years to come to fruition.
Medical Device Business Strategies

Molecular Diagnostics--From Tools to Tests

Instrument makers have made big money off the genomics revolution. But as the research market slows, companies are looking for new business opportunities. One area ripe for development: the molecular diagnostics market.
BioPharmaceutical Medical Device

Selected Start-Ups (3/02)

In Vivo briefly summarizes the technologies of these recently founded companies: Advanced In Vitro Cell Technologies SL (Advancell), CABG Medical Inc., EnVivo Pharmaceuticals Inc., GBBC Medica, GeneOhm Sciences Inc. and Intradigm Corp.
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Cancer
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Becton Dickinson & Co.
  • Senior Management
  • Klemm Peter, PhD, Pres. & CEO
    Kyrillos E Jean-Claude, CFO
    Graham Lidgard, VP, R&D
  • Contact Info
  • GeneOhm Sciences Inc.
    Phone: (858) 334-6300
    6146 Nancy Ridge Dr., Ste. 101
    San Diego, CA 92121
    USA
UsernamePublicRestriction

Register